Cullinan Oncology Inc
NASDAQ:CGEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
US |
|
A
|
Airbus SE
XMUN:AIRA
|
NL |
|
A
|
Aptiv PLC
F:D7A
|
IE |
Shareholder Yield
Current shareholder yield for
CGEM is
.
Peers Comparison
Shareholder Yield
Price Appreciation
CGEM Price
Cullinan Oncology Inc
| Average Annual Return | -15.3% |
| Standard Deviation of Annual Returns | 28.1% |
| Max Drawdown | -81% |
| Market Capitalization | 1.2B USD |
| Shares Outstanding | 61 460 000 |
| Percentage of Shares Shorted | 18.9% |
CGEM Return Decomposition
Main factors of price return
Stock Splits
CGEM's latest stock split occurred on Aug 31, 2009
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
The adjusted shares began trading on Aug 31, 2009. This was the only stock split in CGEM's history.